New blood markers could improve liver cancer diagnosis
NCT ID NCT00373347
First seen Apr 19, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study aimed to find new substances in the blood that can more accurately diagnose liver cancer. Researchers analyzed stored blood samples from 573 people, including those with liver cancer, other liver diseases, and hepatitis infections. The goal was to identify markers that could be used alone or alongside the current standard test (AFP) to improve detection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University School of Medicine
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.